scispace - formally typeset
P

Paul Coucke

Researcher at Ghent University

Publications -  238
Citations -  13452

Paul Coucke is an academic researcher from Ghent University. The author has contributed to research in topics: Pseudoxanthoma elasticum & Gene. The author has an hindex of 55, co-authored 212 publications receiving 11905 citations. Previous affiliations of Paul Coucke include Ghent University Hospital & Baylor College of Medicine.

Papers
More filters
Journal Article

Arterial tortuosity syndrome: case report.

TL;DR: A 13-year-old boy who presented with a malformed ascending aorta mimicking coarctation of aorte and a cutis laxa-like facial dysmorphia is reported on, stressing similarities (facial appearance, inguinal herniae, ..) between ATS and autosomal recessive cutis relaxa, both being connective tissue disorders disorganizing the elastin network.
Journal ArticleDOI

The corneoscleral shape in Marfan syndrome.

TL;DR: To investigate the corneoscleral shape in Marfan syndrome (MFS) patients, a large number of patients with MFS have had atypical corneas, and the shape of the orbits is determined through X-ray diffraction.
Journal ArticleDOI

Functional polymorphism in gamma-glutamylcarboxylase is a risk factor for severe neonatal hemorrhage.

TL;DR: A neonate who received vitamin K (VK) supplementation then developed severe late-onset bleeding with abnormal prothrombin time and activated partial thromboplastine time, which revealed a heterozygous single nucleotide polymorphism, which decreases carboxylase activity and induces VK-dependent coagulation deficiency.
Journal ArticleDOI

A reassessment of copy number variations in congenital heart defects : picturing the whole genome

TL;DR: In this paper, the authors performed a retrospective analysis of copy number variations (CNVs) reported in a cohort of 270 CHD patients, and performed a comprehensive reassessment of 138 CNVs of unknown significance (CNV-US), evaluating protein-coding genes, lncRNA genes, and potential interferences with TAD-related geneenhancer interactions.